- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01625507
The Alberta Diet: Effectiveness Study
December 9, 2016 updated by: University of Alberta
The Alberta Diet: a Proposal for Its Implementation
The study hypothesis is that individuals with type 2 diabetes (T2D), who adhere to the PANDA intervention, will have improved compliance with the nutritional therapy recommendations of the Canadian Diabetes Association.
Specific objectives of this proposal: The objectives of the investigators PANDA (Physical Activity and Nutrition for Diabetes in Alberta) are to (a) to devise and evaluate the efficacy of a multi-level, practical, nutrition intervention program that promotes the individual factors required for effective self-management practices AND that explicitly incorporate strategies to improve food availability, accessibility and acceptability and (b) to use these interventions as a means to examine the relationships between food availability, accessibility, acceptability, adherence to Nutrition Therapy Guidelines, and metabolic indicators of diabetes control in people with type 2 diabetes.
Study Overview
Study Type
Interventional
Enrollment (Actual)
73
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 2R3
- Alberta Diabetes Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Type 2 diabetes, and speak/write English.
- Have attended a diabetes education session delivered by their healthcare provider.
Exclusion Criteria:
- Participants with type 1 diabetes, and those who are unable to speak English.
- People with end-stage renal disease or gastrointestinal diseases that require specialized diets will also be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PANDA intervention
12 week nutritional intervention, including 6 classroom/community sessions, plus two sample collection visits.
|
Participants will follow a menu plan and receive training in how to manage their diet in type 2 diabetes, following the recommendations of the Canadian Diabetes Association, 2008
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Total Energy Intake
Time Frame: 4 months
|
Measured using repeated 24 hour dietary recalls (pre and post-intervention)
|
4 months
|
|
Change in Macronutrient Intake
Time Frame: 3 months
|
Measured using repeated 24 hour dietary recalls (pre and post-intervention)
|
3 months
|
|
Change in Nutrient Intake
Time Frame: 3 months
|
Measured using repeated 24 hour dietary recalls (pre and post-intervention)
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hemoglobin A1c
Time Frame: 4 months
|
a surrogate of blood glucose control
|
4 months
|
|
Program Retention
Time Frame: 3 months
|
attendance at meetings
|
3 months
|
|
Change in Body Mass Index
Time Frame: 4 months
|
Actual weight and height used to calculate BMI pre- and post-intervention
|
4 months
|
|
Body Composition
Time Frame: 3 months
|
body fat and fat-free mass
|
3 months
|
|
Change in Blood Biomarkers
Time Frame: 4 months
|
blood lipids: triglyceride, total cholesterol, LDL-cholesterol, HDL-cholesterol
|
4 months
|
|
Change in Perceived Dietary Adherence Questionnaire Score
Time Frame: 4 months
|
Questionnaire assessing self-reported adherence to 9 criteria, whose individual scores (range 0-7) are summed to get the total score.
Maximum total score is 63.
Minimum total score is 0. A higher score means higher dietary adherence.
|
4 months
|
|
Food Acceptability
Time Frame: 4 months
|
questionnaire based on items related to personal and cultural acceptability of the recommended diet
|
4 months
|
|
Food Accessibility
Time Frame: 4 months
|
questionnaire of items related to financial and physical accessibility of foods in the diet recommended for diabetes
|
4 months
|
|
Food Availability
Time Frame: 4 months
|
questionnaire of items related to the availability in local stores of the food items recommended in the diet for diabetes.
|
4 months
|
|
Change in Waist Circumference
Time Frame: 4 months
|
Measured using repeated 24 hour dietary recalls (pre and post-intervention
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Catherine B Chan, PhD, University of Alberta
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
June 19, 2012
First Submitted That Met QC Criteria
June 20, 2012
First Posted (Estimate)
June 21, 2012
Study Record Updates
Last Update Posted (Estimate)
February 6, 2017
Last Update Submitted That Met QC Criteria
December 9, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- RES0013109
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
-
University of PennsylvaniaNational Institute on Aging (NIA); American Heart AssociationRecruitingType 2 Diabetes Mellitus | Type 2 Diabetes | Type II Diabetes Mellitus | Pre-diabetes | Pre-diabetic | Type II Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2DM) | Pre-diabetic StateUnited States
Clinical Trials on PANDA intervention
-
University of British ColumbiaBritish Columbia Children's Hospital; Providence Health & ServicesCompletedPostoperative PainCanada
-
Zhejiang UniversitySecond Affiliated Hospital of Nanchang University; Lishui Municipal Central...Active, not recruiting
-
University of British ColumbiaCompletedPostoperative Pain | Anesthesia, ConductionCanada
-
University of British ColumbiaCompletedAcute Post-operative PainCanada
-
University of PennsylvaniaChildren's Hospital of PhiladelphiaRecruitingNeurodevelopmental Disorders | Pediatric ALL | Infant DevelopmentUnited States
-
Sharp HealthCareGE Healthcare; Sharp Mary Birch Hospital for Women & NewbornsCompletedPremature Infant | Extreme Prematurity | Extremely Low Birth WeightUnited States
-
University MariborRecruiting
-
Agentschap NLWithdrawn
-
UNC Lineberger Comprehensive Cancer CenterSuspendedSquamous Cell Carcinoma of Head and Neck | Squamous Non-small Cell Lung Cancer | Squamous Cell Lung CancerUnited States
-
Biolux Research Holdings, Inc.TerminatedOrthodontic Tooth MovementCanada